166 related articles for article (PubMed ID: 10285639)
1. Monitoring of clinical investigations; availability of guideline--FDA. Notice.
Fed Regist; 1988 Feb; 53(31):4723-4. PubMed ID: 10285639
[TBL] [Abstract][Full Text] [Related]
2. Protection of human subjects; standards for institutional review boards for clinical investigations--Food and Drug Administration. Final rule.
Fed Regist; 1981 Jan; 46(17 pt 2):8958-79. PubMed ID: 10249529
[TBL] [Abstract][Full Text] [Related]
3. International conference on harmonisation; guidance on statistical principles for clinical trials; availability--FDA. Notice.
Fed Regist; 1998 Sep; 63(179):49583-98. PubMed ID: 10185190
[TBL] [Abstract][Full Text] [Related]
4. Protection of human subjects; informed consent--Food and Drug Administration. Final rule.
Fed Regist; 1981 Jan; 46(17 pt 2):8942-58. PubMed ID: 10249528
[TBL] [Abstract][Full Text] [Related]
5. International Conference on Harmonisation; choice of control group and related issues in clinical trials; availability. Notice.
Food and Drug Administration, HHS
Fed Regist; 2001 May; 66(93):24390-1. PubMed ID: 12356096
[TBL] [Abstract][Full Text] [Related]
6. The FDA's role in medical device clinical studies of human subjects.
Saviola J
J Neural Eng; 2005 Mar; 2(1):S1-4. PubMed ID: 15876645
[TBL] [Abstract][Full Text] [Related]
7. Lessons learned from independent central review.
Ford R; Schwartz L; Dancey J; Dodd LE; Eisenhauer EA; Gwyther S; Rubinstein L; Sargent D; Shankar L; Therasse P; Verweij J
Eur J Cancer; 2009 Jan; 45(2):268-74. PubMed ID: 19101138
[TBL] [Abstract][Full Text] [Related]
8. International Conference on Harmonisation; draft guidance on E2F Development Safety Update Report; availability. Notice.
Food and Drug Administration, HHS
Fed Regist; 2008 Aug; 73(151):45462-3. PubMed ID: 18949880
[TBL] [Abstract][Full Text] [Related]
9. International Conference on Harmonisation; guidance on S7A safety pharmacology studies for human pharmaceuticals; availability. Notice.
Food and Drug Administration, HHS
Fed Regist; 2001 Jul; 66(135):36791-2. PubMed ID: 12356097
[TBL] [Abstract][Full Text] [Related]
10. Year 2000 (Y2K) computer compliance guide; guidance for FDA personnel. Food and Drug Administration. Notice.
Fed Regist; 1999 May; 64(93):26424-6. PubMed ID: 10558534
[TBL] [Abstract][Full Text] [Related]
11. Draft guidance for industry; container and closure integrity testing in lieu of sterility testing as a component of the stability protocol for sterile products; availability--FDA. Notice.
Fed Regist; 1998 Jan; 63(18):4272-3. PubMed ID: 10177326
[TBL] [Abstract][Full Text] [Related]
12. International Conference on Harmonisation; Guidance on M3(R2) Nonclinical Safety Studies for the Conduct of Human Clinical Trials and Marketing Authorization for Pharmaceuticals; availability. Notice.
Food and Drug Administration, HHS
Fed Regist; 2010 Jan; 75(13):3471-2. PubMed ID: 20349552
[TBL] [Abstract][Full Text] [Related]
13. International Conference on Harmonisation; guidance on ethnic factors in the acceptability of foreign clinical data; availability--FDA. Notice.
Fed Regist; 1998 Jun; 63(111):31790-6. PubMed ID: 10180134
[TBL] [Abstract][Full Text] [Related]
14. Draft guidance for industry on developing medical imaging drugs and biologics; availability--FDA. Availability of guidance.
Fed Regist; 1998 Oct; 63(198):55067-9. PubMed ID: 10185833
[TBL] [Abstract][Full Text] [Related]
15. FDA overview and current challenges in regulation of human subject protection. Food and Drug Administration.
Nightingale SL
J Int Assoc Physicians AIDS Care; 1997 Jan; 3(1):24-6. PubMed ID: 11363959
[TBL] [Abstract][Full Text] [Related]
16. International Conference on Harmonisation; guidance on E14 Clinical Evaluation of QT/QTc Interval Prolongation and Proarrhythmic Potential for Non-Antiarrhythmic Drugs; availability. Notice.
Food and Drug Administration, HHS
Fed Regist; 2005 Oct; 70(202):61134-5. PubMed ID: 16237860
[TBL] [Abstract][Full Text] [Related]
17. International Conference on Harmonisation; draft guidance on specifications: test procedures and acceptance criteria for biotechnological/biological products--FDA. Notice.
Fed Regist; 1998 Jun; 63(110):31506-13. PubMed ID: 10180131
[TBL] [Abstract][Full Text] [Related]
18. Prior notice of imported food under the Public Health Security and Bioterrorism Preparedness and Response Act of 2002. Final rule.
Food and Drug Administration, HHS
Fed Regist; 2008 Nov; 73(217):66293-410. PubMed ID: 19112701
[TBL] [Abstract][Full Text] [Related]
19. Strengthening the regulation of clinical trials and bioresearch monitoring.
FDA Consum; 2006; 40(6):35. PubMed ID: 17333566
[TBL] [Abstract][Full Text] [Related]
20. International Conference on Harmonisation; guidance on E11 clinical investigation of medicinal products in the pediatric population; availability. Notice.
Food and Drug Administration, HHS
Fed Regist; 2000 Dec; 65(242):78493-4. PubMed ID: 12362934
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
